CYCLEZYME AB

CYCLEZYME AB

NNGM:CYCLE
25.60
SEK
+0.90
(+3.64%)
No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

Sector
Process industries
Industry
Chemicals: specialty
Address
Lund Sweden
IPO Date
Dec 22, 2023
Business
Cyclezyme AB is a Sweden-based biotechnology company that develops enzyme-based technologies and bioprocesses for the sustainable depolymerization and circular recycling of plastics and synthetic textiles. Founded in 2020 and headquartered in Lund, Sweden, the company operates within the industrial biotechnology and clean technology sectors, targeting plastic packaging manufacturers, textile producers, waste management operators, and chemical recyclers. Cyclezyme AB provides specialized enzymatic solutions and biotechnology laboratory services structured into primary offerings: enzymatic recycling platforms, utilizing engineered biocatalytic enzymes to break down polyethylene terephthalate (PET) and polyamide (nylon) polymers into purified chemical monomers under mild operational conditions without aggressive chemical solvents; contract research and laboratory services (Lab-as-a-Service), providing gene cloning, recombinant protein expression, microbial cell cultivation, and chromatographic protein purification; analytical testing services, encompassing enzyme assays, high-performance liquid chromatography (HPLC) quantitative and qualitative analyses, polymer degradation benchmarking, and feedstock qualification studies to assess plastic waste stream compatibility; and joint technical project development, assisting industrial partners in scaling biocatalytic recycling systems from bench-scale validation to industrial pilots. In recent strategic and operational developments, Cyclezyme AB entered into an industrialization partnership with Meccom Industripartner AB to design, manufacture, install, and service mechanical processing systems for customer deployments; advanced its joint development collaboration with U.S.-based Albany International to scale enzymatic recycling of high-performance industrial polyester and polyamide textiles; and collaborated with the Research Institutes of Sweden (RISE) on industrial enzyme scaling. Furthermore, the company was granted European patent EP4534591 for its microwave-assisted enzymatic polyester depolymerization process, entered into an intellectual property acquisition agreement with Ragn-Sells Recycling AB for a patented biotechnological melanin production method, established a dedicated subsidiary, MelaNova Bioscience AB, to commercialize melanin applications, and completed directed share issues to strategic investors to fund ongoing research, scale-up, and commercial operations.